Product NDC: | 0173-0363 |
Proprietary Name: | ZANTAC |
Non Proprietary Name: | ranitidine hydrochloride |
Active Ingredient(s): | 25 mg/mL & nbsp; ranitidine hydrochloride |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0173-0363 |
Labeler Name: | GlaxoSmithKline LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019090 |
Marketing Category: | NDA |
Start Marketing Date: | 19891001 |
Package NDC: | 0173-0363-00 |
Package Description: | 40 mL in 1 VIAL, PHARMACY BULK PACKAGE (0173-0363-00) |
NDC Code | 0173-0363-00 |
Proprietary Name | ZANTAC |
Package Description | 40 mL in 1 VIAL, PHARMACY BULK PACKAGE (0173-0363-00) |
Product NDC | 0173-0363 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ranitidine hydrochloride |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19891001 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | RANITIDINE HYDROCHLORIDE |
Strength Number | 25 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |